• The New Money
  • Posts
  • Hedge Fund Uranium Stocks, Dog Longevity Science, and Molecular Farming

Hedge Fund Uranium Stocks, Dog Longevity Science, and Molecular Farming

Uncovering the world’s most exciting early stage companies. Discover what’s next.

Top Hedge Funds Are Doubling Down on Uranium Stocks

Top hedge funds including Terra Capital, Segra Capital, and Argonaut Capital Partners have released public filings showing bets on publicly-listed uranium companies. After being out of public favour the past decade, uranium is now gaining acceptance and government support as a clean power source.

The price of physical uranium is up 120% in the past three years, and the total capital invested in uranium ETFs has increased by a staggering 20x over the same period.

Longevity Clinical Trial Launches For Dogs

Silicon Valley based startup Loyal is launching a clinical trial to validate their therapeutic drug for extending the lifespan of dogs. The trial is widely seen as the largest clinical trial ever for veterinary medicine and, if proven successful, could have major implications for the pursuit of new human health and longevity treatments.

Big Oil Wants in on Green Tech Startups

BP Ventures, the multinational oil giant’s VC arm, publicly stated that they will focus almost exclusively on funding green technology startups moving forward, and plans to deploy $200 million in new startup investments this year.

The Sprint

Trending Now